219 related articles for article (PubMed ID: 35639147)
21. Impact of Revision of the LR-M Criteria on the Diagnostic Performance of Contrast-Enhanced Ultrasound LI-RADS.
Ding J; Qin Z; Zhou Y; Zhou H; Zhang Q; Wang Y; Jing X; Wang F
Ultrasound Med Biol; 2021 Dec; 47(12):3403-3410. PubMed ID: 34598799
[TBL] [Abstract][Full Text] [Related]
22. Combined hepatocellular-cholangiocarcinoma: can we use contrast-enhanced ultrasound Liver Imaging Reporting and Data System (LI-RADS) to predict the patient's survival?
Yang J; Huang JY; Chen X; Ling WW; Luo Y; Shi YJ; Liu JB; Lu Q; Lyshchik A
Eur Radiol; 2021 Aug; 31(8):6397-6405. PubMed ID: 33492470
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of the Time Difference Method in Identifying Hepatocellular Carcinoma in Current CEUS LR-M Category Nodules.
Shao LJ; Wang YJ; Yin SS; Jiang BB; Liu YH; Wang JC; Yang W; Wu W; Yan K
Ultrasound Med Biol; 2024 Apr; 50(4):502-508. PubMed ID: 38246805
[TBL] [Abstract][Full Text] [Related]
24. The diagnostic value of contrast-enhanced ultrasound LI-RADS for hepatocellular carcinoma in patients with cirrhosis and chronic hepatitis B.
Yang D; Hu H; Li R; Tang CL; Ma KS; Guo DY
Abdom Radiol (NY); 2022 Feb; 47(2):630-639. PubMed ID: 34910237
[TBL] [Abstract][Full Text] [Related]
25. LR-M Observations on Contrast-Enhanced Ultrasound: Detection of Hepatocellular Carcinoma Using Additional Features in Comparison With Current LI-RADS Criteria.
Xian MF; Huang Y; Xie WX; Pan KM; Zeng D; Huang H; Li MD; Xie XY; Kuang M; Lu MD; Chen LD; Wang W
AJR Am J Roentgenol; 2022 Jul; 219(1):76-85. PubMed ID: 34910538
[No Abstract] [Full Text] [Related]
26. Combining serum AFP and CEUS LI-RADS for better diagnostic performance in Chinese high-risk patients.
Gong W; Wu J; Wei H; Jiang Z; Wan M; Wu C; Xue W; Ma R; Zhou X; Zhou H
Radiol Med; 2023 Apr; 128(4):393-401. PubMed ID: 36943653
[TBL] [Abstract][Full Text] [Related]
27. Comparison of Contrast-Enhanced Ultrasound versus Contrast-Enhanced Magnetic Resonance Imaging for the Diagnosis of Focal Liver Lesions Using the Liver Imaging Reporting and Data System.
Wang JY; Feng SY; Yi AJ; Zhu D; Xu JW; Li J; Cui XW; Dietrich CF
Ultrasound Med Biol; 2020 May; 46(5):1216-1223. PubMed ID: 32115307
[TBL] [Abstract][Full Text] [Related]
28. LI-RADS-CEUS - Proposal for a Contrast-Enhanced Ultrasound Algorithm for the Diagnosis of Hepatocellular Carcinoma in High-Risk Populations.
Schellhaas B; Wildner D; Pfeifer L; Goertz RS; Hagel A; Neurath MF; Strobel D
Ultraschall Med; 2016 Dec; 37(6):627-634. PubMed ID: 27486793
[No Abstract] [Full Text] [Related]
29. Usefulness of Modified CEUS LI-RADS for the Diagnosis of Hepatocellular Carcinoma Using Sonazoid.
Sugimoto K; Kakegawa T; Takahashi H; Tomita Y; Abe M; Yoshimasu Y; Takeuchi H; Kasai Y; Itoi T
Diagnostics (Basel); 2020 Oct; 10(10):. PubMed ID: 33076435
[TBL] [Abstract][Full Text] [Related]
30. Use of CEUS LI-RADS for the Accurate Diagnosis of Nodules in Patients at Risk for Hepatocellular Carcinoma: A Validation Study.
Makoyeva A; Kim TK; Jang HJ; Medellin A; Wilson SR
Radiol Imaging Cancer; 2020 Mar; 2(2):e190014. PubMed ID: 33778701
[TBL] [Abstract][Full Text] [Related]
31. Critical analysis of major and ancillary features of LI-RADS v2018 in the differentiation of small (≤ 2 cm) hepatocellular carcinoma from dysplastic nodules with gadobenate dimeglumine-enhanced magnetic resonance imaging.
De Gaetano AM; Catalano M; Pompili M; Marini MG; Rodríguez Carnero P; Gullì C; Infante A; Iezzi R; Ponziani FR; Cerrito L; Marrone G; Giuliante F; Ardito F; Rapaccini GL; Vecchio FM; Giraldi L; Manfredi R;
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7786-7801. PubMed ID: 31599447
[TBL] [Abstract][Full Text] [Related]
32. An assessment of liver lesions using a combination of CEUS LI-RADS and AFP.
Li CQ; Huang H; Ruan SM; Hu HT; Xian MF; Xie XY; Lu MD; Kuang M; Wang Y; Chen LD
Abdom Radiol (NY); 2022 Apr; 47(4):1311-1320. PubMed ID: 35122491
[TBL] [Abstract][Full Text] [Related]
33. Pathological considerations of CEUS LI-RADS: correlation with fibrosis stage and tumour histological grade.
Cheng MQ; Hu HT; Huang H; Pan JM; Xian MF; Huang Y; Kuang M; Xie XY; Li W; Wang W; Lu MD
Eur Radiol; 2021 Aug; 31(8):5680-5688. PubMed ID: 33502556
[TBL] [Abstract][Full Text] [Related]
34. Tumor size-based validation of contrast-enhanced ultrasound liver imaging reporting and data system (CEUS LI-RADS) 2017 for hepatocellular carcinoma characterizing.
Pan JM; Chen W; Zheng YL; Cheng MQ; Zeng D; Huang H; Huang Y; Xie XY; Lu MD; Kuang M; Hu HT; Chen LD; Wang W
Br J Radiol; 2021 Oct; 94(1126):20201359. PubMed ID: 34545763
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of LI-RADS 3 category by magnetic resonance in US-detected nodules ≤ 2 cm in cirrhotic patients.
Darnell A; Rimola J; Belmonte E; Ripoll E; Garcia-Criado Á; Caparroz C; Díaz-González Á; Vilana R; Reig M; Ayuso C; Bruix J; Forner A
Eur Radiol; 2021 Jul; 31(7):4794-4803. PubMed ID: 33409789
[TBL] [Abstract][Full Text] [Related]
36. Inter-reader agreement of CEUS LI-RADS among radiologists with different levels of experience.
Li W; Li L; Zhuang BW; Ruan SM; Hu HT; Huang Y; Lin MX; Xie XY; Kuang M; Lu MD; Chen LD; Wang W
Eur Radiol; 2021 Sep; 31(9):6758-6767. PubMed ID: 33675388
[TBL] [Abstract][Full Text] [Related]
37. Differences between CEUS LI-RADS and CECT LI-RADS in the diagnosis of focal liver lesions in patients at risk for HCC.
Wen R; Huang W; Song R; Qin L; Wu Y; Peng Y; Huang X; He Y; Yang H
BMC Med Imaging; 2023 Sep; 23(1):122. PubMed ID: 37697248
[TBL] [Abstract][Full Text] [Related]
38. Fat-containing hepatocellular carcinoma in patients with cirrhosis: proposal of a diagnostic modification regarding enhancement characteristics.
Delagnes A; Roux M; Vilgrain V; Guiu B; Laurent V; Sutter O; Bricault I; Trillaud H; Aubé C; Paisant A
Eur Radiol; 2024 Apr; 34(4):2283-2293. PubMed ID: 37816923
[TBL] [Abstract][Full Text] [Related]
39. Interobserver and intermodality agreement of standardized algorithms for non-invasive diagnosis of hepatocellular carcinoma in high-risk patients: CEUS-LI-RADS versus MRI-LI-RADS.
Schellhaas B; Hammon M; Strobel D; Pfeifer L; Kielisch C; Goertz RS; Cavallaro A; Janka R; Neurath MF; Uder M; Seuss H
Eur Radiol; 2018 Oct; 28(10):4254-4264. PubMed ID: 29675659
[TBL] [Abstract][Full Text] [Related]
40. Sonazoid-enhanced ultrasonography: comparison with CT/MRI Liver Imaging Reporting and Data System in patients with suspected hepatocellular carcinoma.
Hwang JA; Jeong WK; Min JH; Kim YY; Heo NH; Lim HK
Ultrasonography; 2021 Oct; 40(4):486-498. PubMed ID: 33745266
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
